ROWLEY D A, FITCH F W
J Exp Med. 1965 May 1;121(5):671-81. doi: 10.1084/jem.121.5.671.
Previous studies suggested that an active immune response was partially responsible for maintaining immunological unresponsiveness to sheep erythrocytes. Measurement of the plaque-forming (antibody-releasing) cell response proved to be a sensitive indicator of an immune response to sheep erythrocytes in the absence of detectable circulating antibody to the antigen. The present studies were undertaken to determine whether an active immune process, measured by the plaque-forming cell response, was partially responsible for induction and maintenance of tolerance. Rats injected intraperitoneally with large doses of sheep erythrocytes beginning at the day of birth develop tolerance to the antigen. In this paper, the plaque-forming cell and antibody response to sheep erythrocytes was characterized for rats receiving a single antigen injection at various ages and for rats which received repeated antigen injections as adults. The dose of antigen was the same as that used to produce tolerance; the injection schedule for repeated immunizations was also the same as that used to produce tolerance. Rats receiving a single antigen injection on the day of birth or at age 7 days had no measurable response to the antigen. Rats receiving a single antigen injection at age 17 days and sacrificed 4 days later had an unequivocal response to the antigen. The spleens had about one-tenth as many plaque-forming cells as spleens of adult animals immunized similarly, but the antibody titers were as high as titers for adult animals. Presumably the high titers of these young animals resulted from the high ratio of plaque-forming cells to body weight and blood volume. Adult animals receiving a single antigen injection had a peak or near peak plaque-forming cell response 4 days after immunization; at this time, sera contained high titers of 19S antibody and the numbers of plaque-forming cells in spleens correlated reasonably well with circulating antibody titers. 7S antibody appeared in serum 5 or 6 days after immunization. The numbers of plaque-forming cells declined progressively 2 and 3 weeks after immunization. Repeated twice weekly, injections of the antigen in adult rats produced a marked decline and then stabilization of numbers of plaque-forming cells in spleens. Although the numbers of plaque-forming cells were fewer, titers of 19S and 7S antibody stabilized at high levels. A progressive recovery of the plaque-forming cell response and a rise in antibody titer occurred when the interval between the last 2 injections was increased from 3 to 10, 17, or 32 days. These findings suggested that repeated closely spaced antigen injections interfered with either cell division or maturation of antibody-forming cells. As the interval between injections was increased, additional antibody-forming cells matured or were formed through cell division. Thus, relatively constant antigenic stimulation provided a mechanism for controlling or limiting the response of antibody-forming cells. In the following paper, it will be shown that this mechanism operating together with a homeostatic mechanism which prevents induction of new antibody-forming cells serves to regulate the immune response to repeated injections of antigen.
以往的研究表明,活跃的免疫反应在一定程度上负责维持对绵羊红细胞的免疫无反应性。在缺乏可检测到的针对该抗原的循环抗体的情况下,噬斑形成(抗体释放)细胞反应的测定被证明是对绵羊红细胞免疫反应的敏感指标。本研究旨在确定通过噬斑形成细胞反应测定的活跃免疫过程是否在一定程度上负责耐受性的诱导和维持。从出生当天开始腹腔注射大剂量绵羊红细胞的大鼠会对该抗原产生耐受性。在本文中,对在不同年龄接受单次抗原注射的大鼠以及成年后接受重复抗原注射的大鼠,其对绵羊红细胞的噬斑形成细胞和抗体反应进行了表征。抗原剂量与用于产生耐受性的剂量相同;重复免疫的注射方案也与用于产生耐受性的方案相同。在出生当天或7日龄接受单次抗原注射的大鼠对该抗原没有可测量的反应。在17日龄接受单次抗原注射并在4天后处死的大鼠对该抗原有明确的反应。其脾脏中的噬斑形成细胞数量约为同样免疫的成年动物脾脏的十分之一,但抗体滴度与成年动物的滴度一样高。推测这些幼龄动物的高滴度是由于噬斑形成细胞与体重和血容量的比例较高。接受单次抗原注射的成年动物在免疫后4天有一个峰值或接近峰值的噬斑形成细胞反应;此时,血清中含有高滴度的19S抗体,脾脏中的噬斑形成细胞数量与循环抗体滴度有合理的相关性。7S抗体在免疫后5或6天出现在血清中。免疫后2周和3周,噬斑形成细胞数量逐渐下降。成年大鼠每周两次重复注射抗原,导致脾脏中噬斑形成细胞数量显著下降,然后稳定下来。尽管噬斑形成细胞数量较少,但19S和7S抗体滴度稳定在高水平。当最后两次注射之间的间隔从3天增加到10天、17天或32天时,噬斑形成细胞反应逐渐恢复,抗体滴度上升。这些发现表明,紧密间隔的重复抗原注射干扰了抗体形成细胞的细胞分裂或成熟。随着注射间隔的增加,额外的抗体形成细胞成熟或通过细胞分裂形成。因此,相对恒定的抗原刺激提供了一种控制或限制抗体形成细胞反应的机制。在接下来的论文中,将表明这种机制与防止新的抗体形成细胞诱导的稳态机制共同作用,有助于调节对重复注射抗原的免疫反应。